Natixis Advisors, L.P. Quest Diagnostics Inc Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 92,830 shares of DGX stock, worth $12.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

92,830

Previous 86,211 7.68%

Holding current value

$12.7 Million

Previous $11.8 Million 22.13%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$137.09 - $137.09 $907,398 - $907,398	6,619 Added 7.68%	92,830 $14.4 Million
Q2 2024 Aug 01, 2024	BUY	$125.91 - $144.34 $1.12 Million - $1.28 Million	8,863 Added 11.46%	86,211 $11.8 Million
Q1 2024 Apr 25, 2024	SELL	$123.78 - $142.11 $402,656 - $462,283	-3,253 Reduced 4.04%	77,348 $10.3 Million
Q4 2023 Feb 06, 2024	BUY	$120.62 - $141.12 $3.12 Million - $3.65 Million	25,847 Added 47.21%	80,601 $11.1 Million
Q3 2023 Nov 13, 2023	SELL	$121.86 - $144.92 $2.06 Million - $2.45 Million	-16,873 Reduced 23.56%	54,754 $6.67 Million
Q2 2023 Aug 15, 2023	BUY	$130.56 - $146.84 $1.11 Million - $1.25 Million	8,524 Added 13.51%	71,627 $10.1 Million
Q1 2023 May 11, 2023	BUY	$131.53 - $155.76 $1.5 Million - $1.78 Million	11,410 Added 22.07%	63,103 $8.93 Million
Q4 2022 Jan 27, 2023	BUY	$123.31 - $157.26 $77,068 - $98,287	625 Added 1.22%	51,693 $8.09 Million
Q3 2022 Nov 14, 2022	BUY	$121.77 - $141.1 $440,563 - $510,499	3,618 Added 7.62%	51,068 $6.27 Million
Q2 2022 Aug 12, 2022	SELL	$127.07 - $145.39 $379,939 - $434,716	-2,990 Reduced 5.93%	47,450 $6.31 Million
Q1 2022 May 12, 2022	SELL	$129.09 - $164.35 $50,861 - $64,753	-394 Reduced 0.78%	50,440 $6.9 Million
Q4 2021 Feb 08, 2022	BUY	$140.36 - $173.01 $1.35 Million - $1.66 Million	9,623 Added 23.35%	50,834 $8.8 Million
Q3 2021 Nov 15, 2021	SELL	$132.95 - $158.0 $282,252 - $335,434	-2,123 Reduced 4.9%	41,211 $5.99 Million
Q2 2021 Aug 12, 2021	BUY	$126.66 - $141.48 $1.07 Million - $1.2 Million	8,456 Added 24.24%	43,334 $5.72 Million
Q1 2021 May 05, 2021	BUY	$114.63 - $133.34 $237,054 - $275,747	2,068 Added 6.3%	34,878 $4.48 Million
Q4 2020 Feb 12, 2021	SELL	$112.7 - $128.05 $2.71 Million - $3.08 Million	-24,072 Reduced 42.32%	32,810 $3.91 Million
Q3 2020 Nov 12, 2020	BUY	$107.05 - $130.01 $444,471 - $539,801	4,152 Added 7.87%	56,882 $6.51 Million
Q2 2020 Aug 11, 2020	SELL	$73.34 - $122.61 $1.31 Million - $2.19 Million	-17,846 Reduced 25.29%	52,730 $6.01 Million
Q1 2020 Apr 27, 2020	BUY	$75.14 - $115.68 $603,449 - $929,026	8,031 Added 12.84%	70,576 $5.67 Million
Q4 2019 Feb 10, 2020	BUY	$100.29 - $107.99 $123,757 - $133,259	1,234 Added 2.01%	62,545 $6.68 Million
Q3 2019 Nov 12, 2019	BUY	$97.85 - $107.42 $358,424 - $393,479	3,663 Added 6.35%	61,311 $6.56 Million
Q2 2019 Aug 12, 2019	BUY	$85.18 - $101.94 $2.77 Million - $3.32 Million	32,536 Added 129.56%	57,648 $5.87 Million
Q1 2019 May 15, 2019	BUY	$80.68 - $89.92 $935,403 - $1.04 Million	11,594 Added 85.77%	25,112 $2.26 Million
Q4 2018 Feb 13, 2019	SELL	$79.75 - $108.38 $1.78 Million - $2.42 Million	-22,342 Reduced 62.3%	13,518 $1.13 Million
Q3 2018 Nov 13, 2018	SELL	$105.42 - $114.99 $31,626 - $34,497	-300 Reduced 0.83%	35,860 $3.87 Million
Q2 2018 Aug 14, 2018	SELL	$97.35 - $113.14 $155,760 - $181,024	-1,600 Reduced 4.24%	36,160 $0
Q1 2018 May 10, 2018	SELL	$96.42 - $107.88 $409,977 - $458,705	-4,252 Reduced 10.12%	37,760 $3.79 Million
Q4 2017 Feb 14, 2018	BUY	$90.86 - $100.24 $149,192 - $164,594	1,642 Added 4.07%	42,012 $4.14 Million
Q3 2017 Nov 14, 2017	BUY	$91.96 - $108.35 $3.71 Million - $4.37 Million	40,370	40,370 $3.78 Million

Others Institutions Holding DGX

# of Institutions

925

Shares Held

95.1M

Call Options Held

379K

Put Options Held

354K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Quest Diagnostics Inc Transaction History